Natixis’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $261K | Buy |
4,742
+3,382
| +249% | +$186K | ﹤0.01% | 751 |
|
|
2025
Q1 | $95.7K | Buy |
+1,360
| New | +$95.7K | ﹤0.01% | 771 |
|
|
2024
Q4 | – | Sell |
-79
| Closed | -$5.55K | – | 1033 |
|
|
2024
Q3 | $5.55K | Buy |
+79
| New | +$5.55K | ﹤0.01% | 856 |
|
|
2024
Q2 | – | Sell |
-40,315
| Closed | -$3.52M | – | 993 |
|
|
2024
Q1 | $3.52M | Sell |
40,315
-247,093
| -86% | -$21.6M | 0.02% | 340 |
|
|
2023
Q4 | $27.7M | Sell |
287,408
-211,293
| -42% | -$20.4M | 0.2% | 99 |
|
|
2023
Q3 | $44.1M | Buy |
498,701
+436,729
| +705% | +$38.6M | 0.34% | 59 |
|
|
2023
Q2 | $5.37M | Sell |
61,972
-9,203
| -13% | -$798K | 0.04% | 276 |
|
|
2023
Q1 | $6.92M | Sell |
71,175
-117
| -0.2% | -$11.4K | 0.06% | 224 |
|
|
2022
Q4 | $7.38M | Sell |
71,292
-147,336
| -67% | -$15.2M | 0.04% | 293 |
|
|
2022
Q3 | $18.5M | Sell |
218,628
-5,000
| -2% | -$424K | 0.09% | 174 |
|
|
2022
Q2 | $18.5M | Sell |
223,628
-619,214
| -73% | -$51.3M | 0.07% | 184 |
|
|
2022
Q1 | $65M | Sell |
842,842
-42,084
| -5% | -$3.24M | 0.23% | 94 |
|
|
2021
Q4 | $78.2M | Sell |
884,926
-407,019
| -32% | -$36M | 0.27% | 62 |
|
|
2021
Q3 | $99.9M | Buy |
1,291,945
+79,355
| +7% | +$6.13M | 0.35% | 51 |
|
|
2021
Q2 | $101M | Buy |
1,212,590
+57,971
| +5% | +$4.84M | 0.44% | 47 |
|
|
2021
Q1 | $87.2M | Sell |
1,154,619
-267,391
| -19% | -$20.2M | 0.29% | 77 |
|
|
2020
Q4 | $125M | Buy |
1,422,010
+799,207
| +128% | +$70.1M | 0.45% | 43 |
|
|
2020
Q3 | $47.4M | Buy |
622,803
+393,237
| +171% | +$29.9M | 0.35% | 75 |
|
|
2020
Q2 | $28.3M | Sell |
229,566
-126,545
| -36% | -$15.6M | 0.22% | 92 |
|
|
2020
Q1 | $30.1M | Sell |
356,111
-31,316
| -8% | -$2.65M | 0.24% | 100 |
|
|
2019
Q4 | $32.8M | Sell |
387,427
-180,783
| -32% | -$15.3M | 0.2% | 130 |
|
|
2019
Q3 | $38.3M | Buy |
568,210
+187
| +0% | +$12.6K | 0.25% | 97 |
|
|
2019
Q2 | $48.7M | Sell |
568,023
-104,288
| -16% | -$8.93M | 0.37% | 63 |
|
|
2019
Q1 | $59M | Buy |
672,311
+133,829
| +25% | +$11.8M | 0.37% | 58 |
|
|
2018
Q4 | $45.9M | Buy |
538,482
+21,053
| +4% | +$1.79M | 0.38% | 66 |
|
|
2018
Q3 | $50.2M | Buy |
+517,429
| New | +$50.2M | 0.29% | 89 |
|
|
2017
Q3 | – | Sell |
-12,257
| Closed | -$1.11M | – | 1251 |
|
|
2017
Q2 | $1.11M | Buy |
+12,257
| New | +$1.11M | 0.01% | 393 |
|
|
2017
Q1 | – | Sell |
-60,732
| Closed | -$5.03M | – | 941 |
|
|
2016
Q4 | $5.03M | Buy |
+60,732
| New | +$5.03M | 0.05% | 259 |
|
|
2015
Q2 | – | Sell |
-1,800
| Closed | -$224K | – | 373 |
|
|
2015
Q1 | $224K | Buy |
+1,800
| New | +$224K | ﹤0.01% | 389 |
|